awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35647173-533943D1-2B05-4B01-9601-174C47FC9657
Q35647173-533943D1-2B05-4B01-9601-174C47FC9657
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35647173-533943D1-2B05-4B01-9601-174C47FC9657
CYP3A4-mediated lopinavir bioactivation and its inhibition by ritonavir.
P2860
Q35647173-533943D1-2B05-4B01-9601-174C47FC9657
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35647173-533943D1-2B05-4B01-9601-174C47FC9657
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99ba43779e997b555293076207109c682654b931
P2860
A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks.